Evrofarma SA (EVROF.AT)
EUR 1.63
(0.93%)
EUR 1.63
(0.93%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 48.76 Million EUR | 7.45% |
| 2022 | 45.38 Million EUR | 23.66% |
| 2021 | 36.69 Million EUR | 8.23% |
| 2020 | 33.9 Million EUR | 1.28% |
| 2019 | 33.47 Million EUR | 1.5% |
| 2018 | 32.98 Million EUR | 6.45% |
| 2017 | 30.98 Million EUR | 7.2% |
| 2016 | 28.9 Million EUR | -2.5% |
| 2015 | 29.64 Million EUR | 17.31% |
| 2014 | 25.27 Million EUR | 7.69% |
| 2013 | 23.46 Million EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 21.64 Million EUR | 0.0% |
| 2023 Q3 | 12.59 Million EUR | 6.95% |
| 2023 FY | 45.38 Million EUR | 0.0% |
| 2023 Q1 | 11.78 Million EUR | -8.27% |
| 2023 Q2 | 11.78 Million EUR | 0.0% |
| 2023 Q4 | 12.59 Million EUR | 0.0% |
| 2022 Q4 | 12.84 Million EUR | 0.0% |
| 2022 Q3 | 12.84 Million EUR | 30.42% |
| 2022 Q1 | 9.84 Million EUR | 3.04% |
| 2022 FY | 45.38 Million EUR | 23.66% |
| 2022 Q2 | 9.84 Million EUR | 0.0% |
| 2021 FY | 36.69 Million EUR | 8.23% |
| 2021 Q1 | 8.79 Million EUR | -51.78% |
| 2021 Q4 | 9.55 Million EUR | 0.0% |
| 2021 Q2 | 17.58 Million EUR | 100.0% |
| 2021 Q3 | 9.55 Million EUR | -45.65% |
| 2020 Q4 | 18.23 Million EUR | 100.0% |
| 2020 FY | 33.9 Million EUR | 1.28% |
| 2020 Q2 | 15.67 Million EUR | 100.0% |
| 2020 Q1 | 7.83 Million EUR | -51.06% |
| 2020 Q3 | 9.11 Million EUR | -41.84% |
| 2019 Q2 | 17.46 Million EUR | 100.0% |
| 2019 FY | 33.47 Million EUR | 1.5% |
| 2019 Q4 | 16.01 Million EUR | 100.0% |
| 2019 Q3 | 8 Million EUR | -54.16% |
| 2019 Q1 | 8.73 Million EUR | 1.74% |
| 2018 Q3 | 8.58 Million EUR | 11.72% |
| 2018 FY | 32.98 Million EUR | 6.45% |
| 2018 Q4 | 8.58 Million EUR | 0.0% |
| 2018 Q2 | 7.68 Million EUR | 0.0% |
| 2018 Q1 | 7.68 Million EUR | -3.11% |
| 2017 Q2 | 7.39 Million EUR | 0.0% |
| 2017 FY | 30.98 Million EUR | 7.2% |
| 2017 Q3 | 7.93 Million EUR | 7.3% |
| 2017 Q4 | 7.93 Million EUR | 0.0% |
| 2017 Q1 | 7.39 Million EUR | -5.43% |
| 2016 FY | 28.9 Million EUR | -2.5% |
| 2016 Q2 | 6.63 Million EUR | 0.0% |
| 2016 Q1 | 6.63 Million EUR | -5.75% |
| 2016 Q4 | 7.81 Million EUR | 0.0% |
| 2016 Q3 | 7.81 Million EUR | 17.73% |
| 2015 Q4 | 7.04 Million EUR | -13.44% |
| 2015 FY | 29.64 Million EUR | 17.31% |
| 2015 Q3 | 8.13 Million EUR | 4.89% |
| 2015 Q2 | 7.75 Million EUR | 15.65% |
| 2015 Q1 | 6.7 Million EUR | 8.47% |
| 2014 FY | 25.27 Million EUR | 7.69% |
| 2014 Q2 | 6.25 Million EUR | 9.11% |
| 2014 Q3 | 7.1 Million EUR | 13.66% |
| 2014 Q4 | 6.18 Million EUR | -12.97% |
| 2014 Q1 | 5.73 Million EUR | -8.31% |
| 2013 Q2 | 5.61 Million EUR | 8.15% |
| 2013 Q3 | 6.41 Million EUR | 14.4% |
| 2013 Q1 | 5.18 Million EUR | 0.0% |
| 2013 FY | 23.46 Million EUR | 0.0% |
| 2013 Q4 | 6.24 Million EUR | -2.65% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 63.53 Million EUR | 23.256% |
| Kri-Kri Milk Industry S.A. | 216.32 Million EUR | 77.46% |
| Loulis Food Ingredients S.A. | 202.74 Million EUR | 75.95% |